Lexeo Therapeutics Inc. Common Stock (LXEO)

Stock · NASDAQ · Health Care

$4.86as of 8/28/2026

Price chart

Insider transactionsShow all transaction typesRevenue Growth

No technical signal is currently active for this symbol.

Support level

$4.48

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Chosen by industry and closest market cap.

LXEO
Lexeo Therapeutics Inc. Common Stock
$4.87
▼ 2.51%
Market cap $329.79MP/E —
FENC
Fennec Pharmaceuticals Inc. Common Stock
$12.19
▲ 3.57%
Market cap $334.56MP/E —
$5.65$13.25
PALI
Palisade Bio Inc. Common Stock
$2.01
▼ 4.74%
Market cap $336.74MP/E 3.25
$0.53$2.86
AGEN
Agenus Inc. Common Stock
$7.67
▼ 1.79%
Market cap $349.96MP/E 4.88
$2.71$8.85
NMRA
Neumora Therapeutics Inc. Common Stock
$1.38
▼ 6.76%
Market cap $303.87MP/E —
$0.83015$3.65
IPSC
Century Therapeutics Inc. Common Stock
$2.03
▼ 9.19%
Market cap $357.10MP/E —
$0.435$3.04
SABS
SAB Biotherapeutics Inc. Common Stock
$3.79
▼ 3.56%
Market cap $289.80MP/E 26.94
$1.85$5.15

Symbol	Market cap	P/E ratio	Price	1D	52-week range
LXEO Lexeo Therapeutics Inc. Common Stock	$329.79M	—	$4.87	▼ 2.51%
FENC Fennec Pharmaceuticals Inc. Common Stock	$334.56M	—	$12.19	▲ 3.57%	$5.65$13.25
PALI Palisade Bio Inc. Common Stock	$336.74M	3.25	$2.01	▼ 4.74%	$0.53$2.86
AGEN Agenus Inc. Common Stock	$349.96M	4.88	$7.67	▼ 1.79%	$2.71$8.85
NMRA Neumora Therapeutics Inc. Common Stock	$303.87M	—	$1.38	▼ 6.76%	$0.83015$3.65
IPSC Century Therapeutics Inc. Common Stock	$357.10M	—	$2.03	▼ 9.19%	$0.435$3.04
SABS SAB Biotherapeutics Inc. Common Stock	$289.80M	26.94	$3.79	▼ 3.56%	$1.85$5.15

P/E shows — for peers not currently carrying a live signal of their own.

March 31, 2026

Top holders this quarter

See the full, filterable feed with live charts on the MarketWall dashboard.